Does OFATUMUMAB Cause Central nervous system lesion? 185 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Central nervous system lesion have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.6% of all adverse event reports for OFATUMUMAB.
185
Reports of Central nervous system lesion with OFATUMUMAB
0.6%
of all OFATUMUMAB reports
1
Deaths
28
Hospitalizations
How Dangerous Is Central nervous system lesion From OFATUMUMAB?
Of the 185 reports, 1 (0.5%) resulted in death, 28 (15.1%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
RITUXIMAB (151)
METHOTREXATE (147)
Which OFATUMUMAB Alternatives Have Lower Central nervous system lesion Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB